β¨ Health and Tax Notices
14 JULY 2011 NEW ZEALAND GAZETTE, No. 105
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland
Product: Diovan
Active Ingredient: Valsartan 160mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturers: Novartis Farmaceutica SA, Barcelona, Spain
Novartis Pharma Stein AG, Stein, Switzerland
Product: Diovan
Active Ingredient: Valsartan 320mg
Dosage Form: Film coated tablet
Dated this 7th day of July 2011.
STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001.
go4708
Inland Revenue
Income Tax Act 2007
Resident Withholding Tax on Interest
Cancelled certificates of exemption for the period 01/04/11 to 30/06/11
[table of cancelled RWT certificate numbers omitted]
Resident Withholding Tax on Interest
Reissued certificates of exemption for the period 01/04/11 to 30/06/11
[table of reissued RWT certificate numbers omitted]
go4727
Next Page →
β¨ LLM interpretation of page content
π₯
Consent to the Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare7 July 2011
Medicines Act, New Medicines, Valsartan, Diovan, Novartis
- STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health
π° Cancelled Certificates of Exemption for Resident Withholding Tax on Interest
π° Finance & RevenueIncome Tax Act 2007, Resident Withholding Tax, Certificates of Exemption, Cancellation
π° Reissued Certificates of Exemption for Resident Withholding Tax on Interest
π° Finance & RevenueIncome Tax Act 2007, Resident Withholding Tax, Certificates of Exemption, Reissue
NZ Gazette 2011, No 105